Mission
The future potential of mRNA therapeutics and vaccines is constrained by legacy manufacturing methods.
Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.